Metastatic HER2-Positive Breast Cancer - WebMD
Mar 17, 2023 · Here's everything you need to know if you or someone you love has just gotten a diagnosis of metastatic HER2-positive breast cancer.
HER2-Positive Breast Cancer: Symptoms & Treatment
HER2-Positive Breast Cancer HER2-positive (HER2+) breast cancer affects some people who have invasive breast cancer. This is a fast-growing cancer that can quickly spread from your …
How we treat patients with metastatic HER2-positive breast cancer
HER2-positive breast cancer represents 15%-20% of breast malignancies and is characterized by an aggressive behavior and high recurrence rates. Anti-HER2-directed agents represent the …
HER2 Breast Cancer: The Basics About This Specific Subtype
5 days ago · HER2 Breast Cancer: The Basics About This Specific Subtype "Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the …
Treatment of Stage IV (Metastatic) Breast Cancer
Systemic (drug) treatments for stage IV breast cancer Treatment often continues until the cancer starts growing again or until side effects become unacceptable. If this happens, other drugs …
HER2-Positive Metastatic Breast Cancer: A Comprehensive Review
Abstract: Cases of human epidermal growth factor receptor 2 (HER2)–positive breast cancer represent approximately 15% to 20% of all breast cancers. Historically, this subtype of breast …
Current Treatment Approaches in HER2+ Metastatic Breast Cancer
Jun 17, 2025 · Panelists discussed how evolving strategies in HER2-positive metastatic breast cancer are shifting toward more personalized maintenance approaches, including the …
HER2-Targeted Therapies for Metastatic Breast Cancer
Mar 3, 2025 · HER2-Targeted Therapies for Metastatic Breast Cancer Watch our June 2024 MBC Impact Series, Metastatic HER2-Positive Breast Cancer. HER2 and metastatic breast cancer …
DESTINY-Breast09: Trastuzumab Deruxtecan Plus Pertuzumab Sets …
Jun 2, 2025 · Dr. Sara M. Tolaney Key Points: DESTINY-Breast09 is the first trial in more than a decade to demonstrate a clinically meaningful improvement in outcomes for a broad group of …
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
Sep 14, 2024 · Trastuzumab Deruxtecan in Metastatic Breast Cancer Results Of the 866 patients who underwent randomization, 713 had HER2-low disease, and 153 had HER2-ultralow disease.